Intelligence Β· Patent portfolio

Tonix Pharmaceuticals Holding Patents

Full USPTO pharma patent portfolio for Tonix Pharmaceuticals Holding β€” grant dates, expiration, and drug cross-links.

Patents
86
Expiring ≀24m
2

Quick answer

Tonix Pharmaceuticals Holding has 86 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 2

  1. US 9402935

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 9314469

    Method for treating neurocognitive dysfunction

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 9314552

    Drug releasing coatings for medical devices

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 9314598

    Drug releasing coatings for balloon catheters

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 9289539

    Drug releasing coatings for medical devices

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 9289537

    Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 9283358

    Drug releasing coatings for medical devices

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 9248220

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 9033919

    Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 9023371

    Drug releasing coatings for medical devices

    Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 9005161

    Drug releasing coatings for medical devices

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 8998847

    Drug releasing coatings for medical devices

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 8998846

    Drug releasing coatings for balloon catheters

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 8932561

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 8815246

    Fc receptor binding proteins

    Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 8481599

    Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 8449884

    Clotting factor-fc chimeric proteins to treat hemophilia

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 8425459

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 8414909

    Drug releasing coatings for medical devices

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 8414526

    Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 8414910

    Drug releasing coatings for medical devices

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 8414525

    Drug releasing coatings for medical devices

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 8403910

    Drug releasing coatings for medical devices

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 8404300

    Drug releasing coatings for medical devices

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 8366660

    Drug releasing coatings for medical devices

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 8366662

    Drug releasing coatings for medical devices

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 8329182

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 8293707

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 8273351

    Fc receptor binding proteins

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 8244344

    Drug releasing coatings for medical devices

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 8241249

    Drug releasing coatings for medical devices

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 8101186

    Peptides that block the binding of IgG to FcRn

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7862820

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7820162

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7601516

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7404956

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7381408

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7348004

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Tonix Pharmaceuticals Holding have?

86 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Tonix Pharmaceuticals Holding patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory